Harrison School of Pharmacy

Graduate Student Directory

Ahmed Mishuk

Ahmed Mishuk

Degree Program: Ph.D., Health Outcomes Research and Policy
Anticipated Graduation: 2020
Advisor: Jingjing Qian, Ph.D.
Email: azm0145@auburn.edu


  • M.S., Pharmaceutical Technology - University of Asia Pacific, 2013

Research Areas:
  • Pharmacoepidemiology and Drug Safety
  • Utilization and Effectiveness of Drugs in Large Populations
  • Impact of Pharmacists on Patient Safety and Public Health
  • Systematic Review and Meta-analysis

Ahmed Mishuk completed his B.Pharm and M.S. in his home country of Bangladesh. He is pursuing his Ph.D. in the Health Outcomes Research and Policy option at the Harrison School of Pharmacy. His research areas are pharmacoepidemiology, drug utilization, and drug safety and his primary interest is working with observational data with emphasis in the analysis of the usage and safety of drugs among general population.

  • Mishuk AU, Fasina I, Qian J. Effects of U.S. Federal and State Generic Drug Policies on Drug Use, Spending, and Patient Outcomes - A Systematic Review. Research in Social and Administrative Pharmacy, 2019, ISSN 1551-7411, https://doi.org/10.1016/j.sapharm.2019.08.031.

  • Fahim SM, Mishuk AU, Cheng N, Hansen R, Calderon AI, Qian J. Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS). Expert opinion on drug safety. In press
  • Qian J, Mishuk AU, Hansen RA. Does public perception bias lead to more frequent reporting of adverse events: branded vs generic drugs. Expert opinion on drug safety. 2018/08/03 2018;17(8):753-756.
  • Mishuk AU, Qian J., Howard J. N., et al. The association between patient sociodemographic characteristics and generic drug use: a systematic review and meta-analysis. Journal of Managed Care & Specialty Pharmacy. 2018;24(3):252–264. doi: 10.18553/jmcp.2018.24.3.252.

Last Updated: January 15, 2020